Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Taltz (ixekizumab) and Bimzelx (bimekizumab) are both medications used to treat moderate-to-severe plaque psoriasis, psoriatic arthritis, and other inflammatory conditions, and belong to the interleukin antagonist class. However, they have several differences. Taltz is typically injected once a month after initial doses, whereas Bimzelx starts with monthly injections and then shifts to every other month. Neither medication has a generic available. Common side effects of Taltz include upper respiratory infections and injection site reactions, while Bimzelx can cause upper respiratory infections and oral thrush, in addition to injection site reactions. Both medications can increase the risk of infections and should be used with caution regarding live vaccines.
Taltz (ixekizumab)
Bimzelx (bimekizumab)
Taltz (ixekizumab)
Bimzelx (bimekizumab)
Summary of Taltz vs. Bimzelx
Summary for Interleukin antagonist
Prescription only
Taltz (ixekizumab) is an injection that's given under the skin. It helps treat inflammatory conditions, including plaque psoriasis, psoriatic arthritis, and some types of arthritis in the spine. This medication works as an interleukin antagonist to lessen inflammation in the body. You inject Taltz (ixekizumab) once a month using the prefilled syringe or autoinjector. The dose depends on the health problem you're treating. Side effects include upper respiratory infections. You also might feel pain or have redness around the injection area. Taltz (ixekizumab) is a brand-name medication.